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and Anil P. Hingorani, MD, Brooklyn, NY
Background: The published results of carotid endarterectomy (CEA) in chronic renal insufficiency (CRI) patients are
contradictory, mostly because of the relatively small number of patients in these studies. To better assess the neurologic
complications and mortality, we reviewed a recent and substantially larger series of CRI patients who underwent CEAs.
Methods: From March 2000 to March 2003, 675 consecutive primary CEAs were performed in 609 patients (346 men,
57%) under general anesthesia. Asymptomatic carotid artery stenosis accounted for 71% of cases. CRI (serum creatinine
level> 1.5mg/dL) was detected in 166 patients (27%) who underwent 184CEAs. The remaining 443 patients (73%) had
491 CEAs.
Results: Patients with CRI were different in age (76  8 years vs 72  9 years, P < .001), male gender (73% vs 51%, P <
.001), coronary artery disease (50% vs 28%, P < .001), and diabetes mellitus incidence (38% vs 27%, P < .02). No
significant difference in stroke rates was observed between the CRI patients and the control group (1.2% vs 0.5%). The
mortality rate for CRI patients was 3%, whereas it was 0% for the control group (P < .002). The 143 CRI patients with
serum creatinine levels from 1.5 to 2.9 mg/dL had a 0.7% mortality rate, whereas it was 17% for 23 patients with serum
creatinine levels of 3 mg/dL or more (P < .001). The stroke rate for the former group was 0.7% and 4.3% for the latter
group (NS). Asymptomatic (16) and symptomatic (7) patients with serum creatinine levels of 3 mg/dL or more had
mortality rates of 13% and 28%, respectively, with P  .6.
Conclusion: The high mortality rate observed in patients with serum creatinine levels of 3 mg/dL or more after CEA calls
for a nonoperative approach in the management of asymptomatic patients. ( J Vasc Surg 2005;41:24-9.)Carotid endarterectomy is known to be a safe and
durable procedure that has been favored over pharmaco-
logic therapy for neurologically symptomatic as well as
asymptomatic patients.1-3 However, it is interesting to note
that the results reported by the Asymptomatic Carotid
Atherosclerosis Study (ACAS) study were not as strikingly
different between the two forms of treatment as the results
obtained by the North American Symptomatic Carotid
Endarterectomy Trial (NASCET) investigators. Therefore,
we can postulate that CEA may not be beneficial to high-
risk patients, particularly if they are asymptomatic. Included
in this cohort of patients are those with severe chronic renal
insufficiency, as they commonly have significant comor-
bidities.4 Although an abundance of articles have been
published on CEA, there appears to be paucity in the
literature dealing with this topic. These reports consist of a
few small series of patients with conflicting postoperative
stroke and mortality rates that varied from 0% to 43%.5-9
The primary objectives of the present article are to
analyze the 1-month results with CEA in patients with
varying degrees of renal insufficiency in this series and to
compare these results with the ones obtained from patients
with normal levels of serum creatinine who underwent
CEAs within the same time interval.
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24METHODS
Patient population. From March 2000 to March
2003, the Vascular Division atMaimonidesMedical Center
in New York City performed 675 consecutive primary
CEAs in 609 patients; 66 patients (10.8%) had staged
bilateral CEAs. There were 346 men (57%) and 263
women (43%) ranging in age from 39 years to 93 years
(mean, 73  9 years). Associated risk factors are listed in
Table I.
Indications for surgery. Preoperative duplex scan-
ning identified at least 60% ipsilateral internal carotid artery
(ICA) stenosis in male patients and at least 70% in female
patients. ICA diameter reduction was directly measured in
transverse and sagittal planes and reported in 10% inter-
vals.1-3,10
Only 193 CEAs (29%) were performed in symptomatic
patients. Stroke, transient ischemic attacks, and amaurosis
fugax were the indications for surgery in 95 (14%), 79
(12%) and 19 (3%) cases, respectively. The remaining pro-
cedures were performed in 482 (71%) asymptomatic cases.
Severe stenosis (80%) was identified in 287 (60%) of 482
asymptomatic cases and in 121 (63%) of 193 of symptom-
atic cases.
Patients with chronic renal insufficiency: Chronic
renal insufficiency (CRI), defined as serum creatinine levels
of 1.5 mg/dL or more, was detected in 166 patients (27%)
who underwent 184 CEAs; of these, 18 (10.8%) under-
went staged bilateral CEAs. Patients’ ages ranged from 39
to 93 years (mean, 76  8 years). There were 121 men
(73%) and 45 women (27%). Associated cardiovascular risk
factors for these patients are shown in Table II. One hun-
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that varied from 1.5 mg/dL to 2.9 mg/dL (group 1) and
the remaining 23 patients had a serum creatinine level of 3
mg/dL or more (group 2). Sixteen patients (9.6%) with
elevated serum creatinine levels were on hemodialysis.
The incidence of symptomatic carotid artery stenosis in
CRI patients was 31% (57/184), whereas it was 28% (137/
491) for the non-CRI patients; this difference was not
statistically significant (P  .4). In patients with CRI,
critical stenosis (80%) was identified preoperatively in 78
(61%) of 127 asymptomatic patients and in 39 (68%) of 57
symptomatic patients.
Surgical technique. All operations were performed
under general anesthesia. Intravenous heparin was used
routinely and the activated clotting time was kept over 300
seconds during the procedure. Anesthesiologists were ad-
vised to keep the systolic blood pressure around 140 mm
Hg during carotid cross-clamp. Indwelling shunts were
deemed necessary in 204 patients (30%) when the systolic
ICA back pressure was below 50 mm Hg. The external
carotid artery (ECA) disease was left undisturbed.11 Tack-
ing sutures were used for flap prevention in the ICA in 85
patients (13%) and in the common carotid artery (CCA) in
53 patients (8%). Redundancy of the carotid artery was
repaired whenever indicated with a posterior transverse
plication technique in 130 patients (18%).12 Synthetic
patches (Vascutek) were used in 669 patients (99.1%). In
the remaining patients (0.9%), the patches were fashioned
from neck veins (1 facial vein, 5 external jugular veins).
Protamine sulfate was given in 574 patients (85%) at the
completion of the procedure to minimize postoperative
hematomas.
Intraoperative duplex scanning. All patients under-
went intraoperative completion duplex scans in the pres-
ence of a registered vascular technologist using an ATL
HDI 5000 scanner. The operating surgeon manipulated an
intraoperative CL 15-7–MHz transducer inserted in a ster-
ile cover filled with acoustic coupling gel. Immediately after
cross-clamp release, the common, internal, and external
carotid arteries were subjected to B-mode imaging in sag-
ittal and transverse planes, color flow imaging, power
Doppler scanning, and spectral waveform analysis. Multiple
hemodynamic parameters were obtained from the ICA,
CCA, and ECA, including mean volume flows, peak sys-
tolic velocities, end diastolic velocities, and resistive indices.
Technical defects that required revision were ICA mobile
Table I. Associated risk factors in 609 patents that
underwent carotid endarterectomy
Risk factor Patients (n) %
Hypertension 426 70
Smoking 225 37
Coronary artery disease 210 33
Diabetes 195 32
Chronic renal insufficiency 166 27flaps  2 mm long, CCA mobile flaps  3 mm long, andany other ICA or CCA technical defects with 30% local
diameter reduction. No action was taken for ECA abnor-
malities such as flaps, residual disease, or thrombi not
protruding into the ICA lumen.13
Statistical analysis. Instat (GraphPad, Inc, San Diego,
Calif) was used to compare demographic data (age, gender,
indications for surgery), mortality, and morbidity in 166
CRI and 443 non-CRI patients. Similar analyses were
performed for 16 dialyzed and 150 non-dialyzed patients in
this series. Multivariate regression analysis was performed
for the correlation of multiple risk factors with early post-
operative death and stroke using SPSS version 8.0 (SPSS,
Inc, Chicago Ill).
RESULTS
Indications for surgery. The incidence of symptom-
atic carotid artery stenosis in CRI patients was 31% and for
non-CRI patients, 28%; this difference was not statistically
significant (P  0.4).
Surgical approach. Intraluminal shunts were used in
33% of the CRI patients and in 18% of the non-CRI
patients (P .4). Twenty-nine percent of the CRI patients
required posterior transverse plication to correct redun-
dancy, whereas 20% of the non-CRI patients had this
adjunctive technique (P  0.8). The average length of the
synthetic patch used to close the arteriotomy was identical
for both groups (37  10 mm). The need for tacking
sutures in the common or internal carotid arteries was not
statistically different between the CRI group (24%) and the
non-CRI group (19%), with a P  0.2.
Comparison of associated risk factors in patients
with and without CRI. The 166 patients in the CRI
group were significantly older than the 443 patients in the
non-CRI group (76  8 years vs 72  9 years), with P 
.0001. We observed a significant male prevalence in the
CRI group (71% vs 51%), with P .0001. The occurrence
of bilateral carotid artery disease was not statistically differ-
ent between the CRI and the non-CRI groups (10.8% vs
10.6%). The incidence of associated risk factors in these
groups of patients is compared in Table III.
Early (30-day) postoperative mortality and morbidity.
Overall, 4 strokes (0.7%) and 5 deaths (0.8%) occurred in
this series of 609 patients, which contributed to a com-
bined early postoperative stroke and mortality rate of 1.3%.
All deaths were cardiac in origin. It is noteworthy that 4 of
Table II. Associated risk factors in 166 chronic renal
insufficiency patients that underwent carotid
endarterectomy
Risk factor Patients (n) %
Hypertension 118 71
Coronary artery disease 83 50
Diabetes mellitus 63 38
Smoking 53 32these 5 patients were on -blockers.
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ity and mortality rates for symptomatic and asymptomatic
patients with and without CRI are summarized in Tables
IV, V, and VI.
The mortality rates for asymptomatic (2/16) and symp-
tomatic (2/7) patients with serum creatinine levels of 3
mg/dL or more were not statistically different (13% vs 28%),
with P .6.
End stage renal disease patients. No statistically sig-
nificant differences were found in the average age of the 16
patients (76  5 years) with end-stage renal disease
(ESRD) and 150 non-ESRD patients (76  8 years), with
P  0.8. Preoperative neurologic symptoms (38% vs 34%,
P  0.8), postoperative stroke (6.2% vs 0.7%, P  0.1),
death (6.2% vs 2.7%, P 0.4), and combined stroke/death
(6.2% vs 3.3%, P  0.5) rates were not statistically signifi-
cant.
Multivariate analysis of risk factors, death, and
stroke. A multivariate regression test was performed for
analysis of variance of themultiple dependent variables such
as gender, age, preoperative neurologic symptoms, hyper-
tension, diabetes mellitus, coronary artery disease, tobacco
use, serum creatinine level (3 mg/dL or 3 mg/dL),
and dialysis by the covariates death and stroke in 166
patients with CRI. A significant relationship (P  .0001)
was reported between the covariate death and the depen-
dent variable serum creatinine level of 3 mg/dL or greater.
DISCUSSION
CEA is a safe and durable operation to treat carotid
stenosis in neurologically symptomatic and asymptomatic
patients. However, this operation may not be as safe in
patients who present with significant comorbidities. One
such associated risk factor is CRI. These patients are gen-
erally sicker and may potentially have worse outcomes in
terms of postoperative stroke and death. Given the need for
nephrotoxic contrast agents during carotid artery angio-
plasty and stenting, the patients not already on hemodialy-
sis may have limited alternatives to open surgery.
Some authors1,7 have reported unacceptable results
with CEA in CRI patients, while others6 have attested to
Table III. Comparison of associated risk factors
incidence between 166 CRI and 443 non-CRI patients*
Risk factor
CRI
patients
incidence
(%)
Non-CRI
patients
incidence
(%) P
Hypertension 71 67 .3
Coronary artery disease 50 25 .0001
Diabetes mellitus 38 27 .02
Smoking history 32 37 .3
Average # of risk factors 1.9  1 1.6  0.97 .001
CRI, Chronic renal insufficiency.
*Chronic renal insufficiency defined as a serum creatinine level 1.5
mg/dL.the safety of CEA in this patient population. These diver-gent results stem primarily from small sample sizes,6,9 over-
all poor results with CEA,9 and lack of CRI stratification.5-8
The current analysis focuses on the outcomes of CEA in
166 uremic and 443 nonuremic patients. The most striking
finding was a significantly increased mortality rate for the
group of patients with the most severe form of renal im-
pairment: those with serum creatinine levels of 3 mg/dL or
greater or those already on hemodialysis.
In the studied population, consents for postmortem
examinations were rarely obtained because of religious
concerns. As a result, the ultimate cause of death in these
patients remains speculative. We believe that these deaths
were all cardiac in origin. It is of interest to note that three
of the four patients who died in this group were on
-blockers. The uremic patients in this series had an in-
creased number of cardiovascular comorbidities, including
older age, diabetes mellitus, and coronary artery disease.
These coexistent risk factors are anticipated from previous
epidemiologic studies. In fact, Coresh et al14 demonstrated
a higher frequency of diabetes mellitus, hypertension, hy-
percholesterolemia, and elevated homocysteine levels in
patients with renal insufficiency.
In longitudinal studies, mortality rates are estimated to
be up to 20 times greater in those with uremia. It has been
estimated that almost half of the deaths in uremic patients
are caused by cardiovascular disease. The effect of renal
insufficiency on adverse outcomes has been principally dis-
cussed in the cardiac literature.15,16 Accordingly, the 1-year
mortality rate after myocardial infarction in patients with
renal insufficiency is 62%, whereas it is 10% to 15% in
patients with normal serum creatinine levels.
One potential explanation for the elevated mortality
rates in the present series could be related to the liberal use
of protamine sulfate (85%). In a previous published survey
of Society for Vascular Surgery and European Society for
Vascular Surgery members, protamine was used in only
54% and 26% of CEAs, respectively.17 Although none of
our patients in this series developed severe intraoperative
hypotensive episodes or allergic reactions, one cannot rule
Table IV. Comparison of early (30-day) postoperative
stroke and death rates in 609 patients according to
various levels of serum creatinine
Postoperative
complication
Patients
P† P‡
A*
(n  443)
B
(n  143)
C
(n  23)
Stroke 2 (0.5%) 1 (0.7%) 1 (4.3%) NS NS
Death 0 1 (0.7%) 4 (17%) .01 .01
Combined 2 (0.5%) 2 (1.4%) 4 (17%) .01 .01
Column A depicts the results obtained in patients with serum creatinine
levels 1.5 mg/dL, column B with serum creatinine levels from 1.5 to 2.9
mg/dL, and column C with serum creatinine levels  3 mg/dL.
*There were no statistically significant differences found between patients in
columns A and B.
†P values for comparison between patients in columns A and C.
‡P values for comparison between patients in columns B and C.out other potential complications of protamine that could
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with serum creatinine levels of 3mg/dL or more. It is
conceivable that the presence of unrecognized pulmonary
hypertension or coronary stenosis and later thrombosis may
have contributed to the high mortality rates in this ill
population.
A second potential explanation for the elevated mortal-
ity rates stems from the performance of hemodialysis. In-
deed, 16 of the 23 patients with serum creatinine levels of
3mg/dL or more were on dialysis. Given the expected
hypercoagulable state observed in postoperative patients, as
well as the many comorbidities in this population, it is likely
that significant hemodynamic instability during dialysis
could have resulted in dire consequences. Although we
were unable to find evidence of such complications in this
series, it is possible that shifts in effective intravascular
volume during dialysis may have contributed to the ob-
served increased mortality in these patients.
Interestingly, the overall stroke rate was comparable
between the nonuremic and uremic patients. Only symp-
tomatic patients with serum creatinine levels of 3mg/dL or
more or those on dialysis (7 patients) fared significantly
worse than the 136 patients in the control group.However,
we believe that these numbers are too small to allow for a
meaningful interpretation of the results because only one
patient had a stroke.
Renal insufficiency has been associated with increased
arterial calcifications, thus increasing the risk of emboliza-
tion during clamping and unclamping. To minimize this
embolization risk, an extensive dissection was performed in
all cases, ensuring soft end points by biplanar palpation
against clamps. Furthermore, all patients underwent patch
angioplasty after endarterectomy. The benefits of comple-
tion duplex examinations have also been extensively de-
scribed in previous publications.13
We made important changes to our practice guidelines
after we reviewed the results of this study. A less aggressive
stand toward endarterectomy in patients with severe renal
insufficiency (serum creatinine level  3mg/dL or hemo-
Table V. Comparison of early (30-day) postoperative
stroke and death rates in 193 symptomatic patients
according to various levels of serum creatinine
Postoperative
complication
Patients
P† P‡
A*
(n  136)
B
(n  50)
C
(n  7)
Stroke 0 1 (2%) 1 (14%) .05 NS
Death 0 1 (2%) 2 (28%) .01 .04
Combined 0 2 (4%) 2 (28%) .01 NS
Column A depicts the results obtained in patients with serum creatinine
 1.5 mg/dL, column B with serum creatinine from 1.5 to 2.9 mg/dL,
column C with creatinine  3 mg/dL.
*There were no statistically significant differences found between patients in
columns A and B.
†P values for comparison between patients in columns A and C.
‡P values for comparison between patients in columns B and C.dialysis) has been instituted. In addition, these patients nowreceive a more rigorous cardiac work-up, including routine
cardiac stress testing, even for those without complaints of
angina pectoris. Whether balloon angioplasty and stenting
of the carotid artery will emerge as a safer alternative in
terms of improved survival in this high-risk patient group
remains to be documented. Lastly, the intraoperative use of
protamine sulphate has been curtailed significantly in all
endarterectomies.
Recognizing the limitations of this retrospective study
with a limited number of severely uremic patients, we still
recommend a nonoperative approach for neurologically
asymptomatic patients who present with coronary artery
disease. The results presented here for neurologically symp-
tomatic patients do not permit us to draw firm conclusions
regarding endarterectomy, and we encourage other inves-
tigators to report their experiences with such patients. In
the meantime, these patients should be informed that they
are at increased risk of postoperative stroke and death
compared with patients who are not uremic and that they
are at increased risk of postoperative death compared with
less severely uremic patients.
In conclusion, the current study raises concerns in
reference to the outcome of carotid endarterectomy in
patients with renal failure. Although the combined stroke/
mortality rates for the series continues to meet American
Heart Association guidelines18 (less than 3% in asymptom-
atic patients, less than 6% in symptomatic ones), a statisti-
cally significant difference was found when the complica-
tion rates in severely uremic patients were examined. These
results are not surprising given the known natural history of
uremic patients.
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Dr Daniel B. Walsh (Lebanon, NH). Dr Ascher and his
group have reviewed their series of six hundred seventy-five carotid
endarterectomies done over the past three years. They found one
hundred sixty-six patients with elevated creatinine, twenty-two of
whom had creatinines above three milligrams per deciliter. The
stroke rate in the entire group was an admirable one point two
percent, not statistically higher than the larger group with normal
renal function.
The disturbing finding in this study is a twenty-eight percent
combined morbidity and mortality in the patients with creatinines
greater than three milligrams per deciliter. Dr Ascher urges caution
in offering endarterectomy to these patients, particularly those
who are asymptomatic, whose risk of stroke without surgery is low.
The questions I have for the authors are when andwhat caused
these deaths? Were these deaths related to the stress of anesthesia
and surgery or to the patient’s chronic disease? Were the causes of
death different in the various comparison groups? Do the authors
have any stroke and survival data from comparable nonoperated
patients?
This information will be critical in determining the appropri-
ateness of endovascular intervention versus a more conservative
noninterventional approach. The results in the analysis of this
paper point out, again, that intervention to treat carotid athero-
sclerosis in asymptomatic patients achieves benefit in only those
who survive for some period of time, especially when the periop-
erative morbidity of the procedure is minimal.
Dr Ascher. All I can tell you, in terms of the morbidity/
morbidities in our patients, is that one patient had a stroke. This
patient was on dialysis, and he died from it. Two patients had a MI
and died within two weeks. One had respiratory failure and aspi-
rated. We believe he aspirated because he had a sudden death, but
it could have been arrhythmia, we don’t know for sure. And one
had multiple organ failure three weeks after the operation. We felt
it was unrelated to the operation, but again, it was within the thirty
days, and the patient, of course, was never discharged alive.
We don’t think that it’s worth doing an asymptomatic carotidany of these people, the results were so good that I don’t think that
we could challenge that at this point. But I would certainly
challenge the high creatinine.
DrWalsh.Well, one other thing, were there people on dialysis
whose creatinines were in the lower group?
Dr Ascher. No. We took care of that. None was less than
three.
DrThomas Panetta (Staten Island, NY). The question comes
out in the group of patients who you’ve identified at high risk. Is
this going to modify your approach? For example, are all these
patients now going to get Persantine Thalliums or maybe even
catheters prior to carotid endarterectomy, or are you going to
reconsider your indications, especially in the asymptomatic pa-
tients who undergo endarterectomy in this group, and maybe
rethink your indications for the asymptomatic patients with regard
to their ultimate survival? Certainly many of these patients don’t
live long, especially the dialysis-dependent patients.
Dr Ascher. I think this is basically the whole point of our paper,
that we already rethought the whole process and, as of today, I would
not operate on any asymptomatic patients with high creatinine. I’d
rather do nothing, basically. I don’t think that we’re adding much to
their survival and certainly we’re adding a lot to their morbidity and
immediate mortality. So we will not do this operation.
Dr Panetta. What about your cardiac evaluations of these
patients?
Dr Ascher. I think that the cardiac evaluation may lead these
patients to undergo open heart surgery with high morbidity and
mortality in itself. I don’t think that I want to screen patients that
are high risk for this procedure. If they are high risk for a carotid
endarterectomy, imagine for open heart surgery. So I would not
subject them to this. Most of the mortalities were not due to MIs
anyway. So I would not say that I should use high creatinine and
carotid disease as a marker for us to study coronary disease.
Dr David R. Campbell (Boston, Mass). We reported our
experience with mostly diabetic patients on dialysis undergoing
distal reconstruction. And what was impressive was that eighty
percent of them died within the next three years, which is a
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whether, in clinical observation in the hospital, patients who are
not diabetics but with abnormal renal function seem to do a lot
better. So did the diabetes and the renal failure give you a higher
incidence of morbidity and mortality in your series?
Dr Ascher. That’s a very good question. We did not look at
this. Because the numbers we were getting were so small, we didn’t
want to add another factor. But it’s a very good question that we
should be looking into, whether we can further stratify those
patients and get really the highest group possible. And you may be
right, maybe diabetes and renal failure are probably the worst
prognostic indicators.
Dr Peter Gloviczki (Rochester, Minn). It looks like serum
creatinine is a marker of complications. I amwondering if it is really
an independent predictor of the complications or whether it is just
a marker. You really need multivariate analysis, I think, to really say
that this is an independent predictor and not other factors in these
patients are responsible for the high rate of complications.
Dr Ascher. It has been shown as an independent indicator of
morbidity and mortality. The patients just have high creatinine.
They’re not necessarily undergoing any operation. I think this
paper shows a little bit of this.
Dr Robert W.Hobson (Newark, NJ). Your conclusion slides
suggest that carotid artery stentingmay be a reasonable alternative.
Have you had any experience in these patients with carotid arterystenting would be a reasonable alternative, we participated in the
Archer trial, data from which was presented by Mark Wolle, and
the dialysis-dependent patients had a much elevated risk of carotid
artery stenting also.
So maybe this is something that excludes carotid artery stent-
ing, just like perhaps the octogenarianmay not be a good candidate
for carotid artery stenting either. So I wonder if you have any
experience with carotid artery stenting in this group, or any com-
ments about the Archer trial or senior age in terms of using
stenting.
Dr Ascher. We have, since we found this data, stopped
operating on these patients with high creatinine, and we started
doing balloon angioplasties. We did four patients, which we actu-
ally did without any dye. They were X-ray-guided only, without a
drop of dye, because they had a high creatinine. And the rest we did
with ultrasound guidance. I have to tell you, with ultrasound
guidance you get a much better picture and it is surprisingly easy.
You can cannulate the internal carotid artery. You see the balloon
expanding. You see the plaque expanding and being pushed out-
side the lumen contour. And also you can place the stent very
precisely in the areas that you want. In addition, you can see the
position of the stent to the wall perfectly and you then diminish the
amount of ballooning that you have to do. So I think we are very
excited with our non-dye approach to carotid stenting, but we
need much more experience before we really can say anythingstenting? And although, intuitively, you’d think the carotid artery about the subject.
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